Key Data Files for this Active Pharmaceutical Ingredient:

Drug Master Files, 21 CFR, and other industry portals Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… Alphagan (brimonidine tartrate ophthalmic solution), 0.5, 0.2 & (P) 0.15%, Allergan NDA 20-490/S7, 20-613/S18 & 21-262/S6 12/20/01 6/19/02 6/19/02 6/19/02 Alphagan P (brimonidine tartrate ophthalmic solution), 0.15%, Allergan NDA 21-262 Brimonidine Tartrate Ophthalmic Solution, 0.2%, Bausch & Lomb ANDA 76-260 5/28/03 Brimonidine Tartrate Ophthalmic Solution, 0.2%, Alcon ANDA 76-254 9/16/03 Brimonidine Tartrate Ophthalmic Solution, 0.2%, Alcon Universal, Ltd. ANDA 76-254   For the latest approval information, locate this drug using this index.